BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 99511)

  • 1. Site dependence for topical absorption of nitroglycerin in rats.
    Horhota ST; Fung HL
    J Pharm Sci; 1978 Sep; 67(9):1345-6. PubMed ID: 99511
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis, disposition and pharmacokinetics of nitroglycerin.
    Curry SH; Aburawi SM
    Biopharm Drug Dispos; 1985; 6(3):235-80. PubMed ID: 3929851
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous absorption of nitroglycerin.
    Noonan PK; Wester RC
    J Pharm Sci; 1980 Mar; 69(3):365-6. PubMed ID: 6770072
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous nitroglycerin absorption in rats.
    Horhota ST; Fung HL
    J Pharm Sci; 1979 May; 68(5):608-12. PubMed ID: 107313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems.
    Chien YW; Keshary PR; Huang YC; Sarpotdar PP
    J Pharm Sci; 1983 Aug; 72(8):968-70. PubMed ID: 6413678
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcutaneous nitroglycerin--ointment or disc?
    Abrams J
    Am Heart J; 1984 Dec; 108(6):1597-600. PubMed ID: 6439020
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of skin-flap survival using nitroglycerin ointment.
    Rohrich RJ; Cherry GW; Spira M
    Plast Reconstr Surg; 1984 Jun; 73(6):943-8. PubMed ID: 6427801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.
    Moe G; Armstrong PW
    Am J Med; 1986 Nov; 81(5):765-70. PubMed ID: 3096133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans.
    Sved S; McLean WM; McGilveray IJ
    J Pharm Sci; 1981 Dec; 70(12):1368-9. PubMed ID: 6798193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute toxicity test on dermal application of NT-1 tape and 10% nitroglycerin (NT-1 ointment)].
    Yoshida R; Yamakita O; Shinomiya M; Morita K
    J Toxicol Sci; 1986 May; 11 Suppl 2():1-9. PubMed ID: 3093689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system.
    Karim A
    Angiology; 1983 Jan; 34(1):11-22. PubMed ID: 6401951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu W
    Lancet; 1984 Jun; 1(8389):1297. PubMed ID: 6145002
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Taylor SH
    Lancet; 1984 Jul; 2(8394):97. PubMed ID: 6146027
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitroglycerin ointment: application and use.
    Trifiletti P
    Crit Care Nurse; 1982; 2(5):46-8. PubMed ID: 6817969
    [No Abstract]   [Full Text] [Related]  

  • 18. Percutaneous absorption of 1,3-dinitroglycerin and a trial of pharmacokinetic analysis.
    Ogiso T; Iwaki M; Kanokogi A; Terao Y
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2829-33. PubMed ID: 2127557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making the most of topical nitroglycerin.
    Weinhardt JA
    RN; 1985 Dec; 48(12):38-40. PubMed ID: 3934737
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.